🇺🇸 FDA
Patent

US 8288439

Methods and compositions for the inhibition of HIV-1 replication

granted A61KA61K38/00A61K48/00

Quick answer

US patent 8288439 (Methods and compositions for the inhibition of HIV-1 replication) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/00, A61K48/00, A61P, A61P31/18